First UK Gene Therapy Trial Significantly Slows Huntington's Disease Progression
TL;DR
Researchers in the UK have trialed a promising gene therapy, AMT-130, which can slow Huntington's disease progression by up to 75% over three years, potentially offering the first effective treatment for this fatal neurodegenerative disorder.
Topics:top-newshealth#amt-130#clinical-trial#gene-therapy#health#huntingtons-disease#neurodegeneration
- Breakthrough Gene Therapy Slows Huntington's Disease by 75% ScienceAlert
- First successful Huntington’s treatment slows disease progression in small study The Washington Post
- Huntington's breakthrough 'amazing' but with 'caveats' BBC
- A clever genetic technique may treat a horrible brain condition The Economist
- Huntington’s disease treated successfully for first time in UK gene therapy trial The Guardian
Want the full story? Read the original reporting
Read on ScienceAlert